Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
I own Pro Medicus Ltd (ASX: PME) shares, Resmed CDI (ASX: RMD) shares and Telix Pharmaceuticals Ltd (ASX: TLX) shares. This article explains why I own PME, RMD and TLX.
Want to value the Pro Medicus Limited (ASX:PME) share price? Here are 6 key metrics you need to consider.
The Pro Medicus Limited (ASX:PME) share price has risen 12.0% since the start of 2024. It’s probably worth asking, ‘is the PME share price top value?’
The Pro Medicus Ltd (ASX:PME) share price is down 2% after reporting its incredible FY25 first-half result and dividend.
The CAR Group Limited (ASX:CAR) share price has increased 20.2% since the start of 2024. It’s probably worth asking, ‘is the CAR share price priced to perfection?’
Is the Pro Medicus Limited (ASX:PME) share price undervalued? Here are 3 reasons you might want to consider PME shares.
The Pro Medicus Limited (ASX:PME) share price is up 194.8% since the start of 2024. It’s probably worth asking, ‘is the PME share price good value?’
The Pro Medicus Ltd (ASX: PME) share price soared approximately 5% after announcing a new contract win.
Want to value the Pro Medicus Limited (ASX:PME) share price? Here are 6 key metrics you need to consider.
